Oct 2023 Nitazene Analogs
Nitazene analogs are a subclass of designer opioids that are structurally different from opioids but attach to the same mu-opioid...
In Practice: Clinical Insights
Sep 2023 Designer Benzodiazepines
Designer benzodiazepines (DZBDs) represent a major public health issue and their prevalence has increased substantially over the last decade.1 Slight...
Aug 2023 What Did My Patient Actually Take? An Overview of Alcohol Results
According to the National Survey on Drug Use and Health conducted in 2015, 86.4% of people over the age of...
Aug 2023 Synthetic Cannabinoids
[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="grid" angled_section="no" text_align="left" background_image_as_pattern="without_pattern" z_index=""][vc_column][vc_column_text css=""]Novel Psychoactive Substances (NPS) are a diverse group of synthetic substances...
Jun 2023 Spotlight on Potential Interactions Involving Behavioral Health & Substance Use Disorder Medications
Drug-drug and drug-food interactions (DDIs) contribute to adverse drug events (ADEs) which can range in severity from mild effects to...
Jun 2023 Polysubstance Use: Fentanyl and Stimulants
The United States is in an overdose epidemic, with the CDC estimating that 106,699 individuals died of a drug-involved overdose...
